Navigation Links
Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
Date:10/6/2008

trexone SR to improve tolerability. The inclusion of forward-looking statements should not be regarded as a representation by Orexigen that any of its plans will be achieved. Actual results may differ from those set forth in this release due to the risk and uncertainties inherent in the Orexigen business, including, without limitation: the progress and timing of the Company's clinical trials; the potential that earlier clinical trials may not be predictive of future results; the ability for Contrave or Empatic to receive regulatory approval on a timely basis or at all; the potential for adverse safety findings relating to Empatic or Contrave to delay or prevent regulatory approval or commercialization, or result in product liability claims; the ability of Orexigen and its licensors to obtain, maintain and successfully enforce adequate patent and other intellectual property protection of its product candidates; and other risks described in the Company's filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and Orexigen undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
4. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
8. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
11. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... -- Vermillion, Inc. (NASDAQ: VRML ), a multivariate ... has appointed Holly B. Bauzon as Vice ... Bauzon has a proven track record in both increasing ... companies. She has more than 20 years of healthcare ... the position of Director, Lab Services Sales and Managed ...
(Date:8/21/2014)... 21, 2014 The spinal column is one of ... Signals carried to and from the brain through the column ... system. Injury or ailment here can be life altering, and ... of control over their body. Though back injury and disease ... there are more options available to make things better than ...
(Date:8/21/2014)... 21, 2014 /CNW/ - The Canadian Epilepsy Alliance (CEA) is ... designed to educate children about the most common neurological disorder ... Explain Epilepsy comic series tells a fictional story based ... school while living with epilepsy. "Despite the ... still so much misinformation and lack of awareness out there," ...
Breaking Medicine Technology:Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3
... 15, 2011 PDI, Inc. (Nasdaq: ... promotional outsource services to established and emerging health care ... partnership with Qforma, the leading provider of advanced analytics ... Through this agreement, PDI will gain access ...
... REDWOOD CITY, Calif., March 15, 2011 – Ingenuity® ... solutions for life science researchers, today announced new ... in IPA®. Processed RNA-Seq datasets can now be ... context of pathways and diseases for a rich ...
Cached Medicine Technology:PDI Announces Exclusive Partnership With Qforma, Leading Provider of Advanced Analytics for Health Sciences Industry 2Ingenuity Announces RNA-Sequencing Workflow Support and First-of-Its-Kind microRNA Filtering Capability With Latest Release of IPA 2Ingenuity Announces RNA-Sequencing Workflow Support and First-of-Its-Kind microRNA Filtering Capability With Latest Release of IPA 3
(Date:8/22/2014)... Texas (PRWEB) August 22, 2014 The ... $297 million in 2013 to $407 million by 2018, ... The company’s latest report “OpportunityAnalyzer Graft-Versus-Host Disease – Opportunity ... which will occur over six major markets (6MM: the ... be strongest in the five European countries (5EU), where ...
(Date:8/22/2014)... 22, 2014 Tug McGraw Foundation and Team ... RWB) to participate in the 39th Annual Marine Corps Marathon ... runners will join forces in coaching, training and participation for ... of our nation's capital and is often referred to as ... Marine Corps Marathon is the largest marathon in the world ...
(Date:8/22/2014)... Diego, CA (PRWEB) August 22, 2014 ... daily regarding all the latest information from the FDA ... , The US FDA announced on August 19, ... Atherectomy Systems, model number DPB-125MICRO145 (Part number 7-10003), by ... contain defective saline sheaths that could fracture during use ...
(Date:8/22/2014)... FastFingerprints is adding a new location ... open Wednesday, August 27, 2014 and is located at ... With the addition of this new office, that will ... the Cleveland area. Our new Cleveland-Midtown location will ... The hours of operation will be Monday-Friday 8:00am – ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Dealing with a ... challenging when the addict is a child. Adolescent substance abuse ... for a long time. But a new helpline is now ... find professional youth rehab for something like a teen ... was designed to help make a positive impact in the ...
Breaking Medicine News(10 mins):Health News:Graft-Versus-Host Disease Treatment Market Worth $409.0m by 2018 Says a New Report Available at MarketOptimizer.org 2Health News:Graft-Versus-Host Disease Treatment Market Worth $409.0m by 2018 Says a New Report Available at MarketOptimizer.org 3Health News:Graft-Versus-Host Disease Treatment Market Worth $409.0m by 2018 Says a New Report Available at MarketOptimizer.org 4Health News:Tug McGraw Foundation and Team Red White and Blue Join to Run in Marine Corps Marathon 2Health News:Tug McGraw Foundation and Team Red White and Blue Join to Run in Marine Corps Marathon 3Health News:Diamondback 360 Peripheral Orbital Atherectomy System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:FastFingerprints Expands In The Cleveland Ohio Area 2Health News:FastFingerprints Expands In The Cleveland Ohio Area 3Health News:Cincinnati’s New Troubled Teen Helpline is Making a Difference in the Community 2
... Reporter , MONDAY, March 26 (HealthDay News) -- Here,s a ... who eat chocolate regularly are somewhat skinnier than folks who ... that chowing down on chocolate will melt off your excess ... modest difference in body mass, or it might be a ...
... honored with the Distinguished Sonographer Award during the 2012 ... at the JW Marriott Desert Ridge Resort and Spa ... Sonographer Award is a means of recognizing and honoring ... to the growth and development of medical ultrasound. ...
... Lisa Esposito HealthDay Reporter , THURSDAY, March ... initiative since the Medicare and Medicaid programs of the ... presidency, is about to face its biggest challenge. ... unprecedented six hours of arguments over three days on ...
... , MONDAY, March 26 (HealthDay News) -- ... leading cause of death among women in the United ... clinics, a new study suggests. Researchers from ... that heart screenings performed during visits to obstetrician/gynecologists could ...
... cancer researcher Professor Jane Visavader has been selected to ... The fellowship recognises Professor Visvader,s research over the past ... that can give rise to all types of cells ... which different types of breast cancer arise., Professor Visvader, ...
... offering in late March a new stereotactic radiosurgery ... available. The new imaging and radiosurgery ... fast and precise noninvasive image-guided radiation therapy. Radiosurgery ... with high precision to a tumor. "Radiosurgery ...
Cached Medicine News:Health News:Does Chocolate Help You Stay Slim? 2Health News:Does Chocolate Help You Stay Slim? 3Health News:Supreme Court Prepares to Tackle Affordable Care Act 2Health News:Supreme Court Prepares to Tackle Affordable Care Act 3Health News:Supreme Court Prepares to Tackle Affordable Care Act 4Health News:Supreme Court Prepares to Tackle Affordable Care Act 5Health News:Supreme Court Prepares to Tackle Affordable Care Act 6Health News:Ob/Gyn Visit a Good Time to Screen for Heart Disease: Study 2Health News:Professor Jane Visvader elected to Australian Academy of Science 2Health News:Cancer treatment system sculpts radiation beam to match shape of a tumor 2
... key challenges. Reducing costs while adjusting to ... Meeting ever-increasing expectations from more informed customers. ... with labor shortages. Providing value in managing ... theres targeted relief from a trusted partner ...
... The Roche Diagnostics Task Targeted ... state-of-the-art automation of pre- ... laboratories: decapping, sorting / archiving ... into bar code labeled secondary ...
... 20 years of experience in providing ... Life Sciences, the Freedom EVO platform ... for expansion according to future needs., ... Freedom EVOware, each system is equipped ...
... designed a flexible liquid handling system that ... three liquid handlers all on the same ... for targeted applications or custom-tailored to meet ... provide comprehensive systems that combine all the ...
Medicine Products: